{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:11:18Z","timestamp":1779207078832,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Urothelial carcinoma (UC) is a common malignancy with high recurrence rates and limited prognostic markers. Inflammation and stress-response pathways are implicated in tumor progression, with NF-\u03baB, interleukin-8 (IL-8), and heat shock proteins (HSP90\u03b1\/\u03b2) playing key roles in survival signaling and treatment resistance. We evaluated the expression of these proteins in UC and assessed their associations with clinicopathological features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Formalin-fixed, paraffin-embedded samples from 102 UC patients (168 tumor sections) and 23 controls were analyzed by immunohistochemistry for NF-\u03baB, IL-8, HSP90\u03b1, and HSP90\u03b2. Expression was semi-quantitatively scored using the immunoreactive score (IRS) and correlated with clinicopathological features using non-parametric tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nuclear NF-\u03baB expression was significantly higher in UC compared with normal urothelium and correlated with tumor stage and nodal involvement. IL-8 was expressed in 53.6% of tumors and 48.8% of adjacent infiltrates but showed no association with grade, stage, or lymph node status; a weak positive correlation with inflammatory infiltrate was observed. Both HSP90 isoforms were upregulated in UC relative to controls, but only HSP90\u03b2 correlated with grade, stage, and lymph node status. No significant correlations were found between NF-\u03baB, IL-8, and HSP90 expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HSP90\u03b2 expression shows potential as a prognostic biomarker and therapeutic target in UC. Although NF-\u03baB and IL-8 did not demonstrate consistent prognostic value, their patterns highlight the role of inflammatory signaling in tumor biology. These findings warrant validation in larger, more diverse cohorts and support exploration of HSP90-targeted strategies in UC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12094-025-04181-9","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T13:24:45Z","timestamp":1766496285000},"page":"2335-2344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HSP90\u03b2 as a potential prognostic biomarker in urothelial carcinoma: insights from NF-\u03baB, IL-8, and heat-shock protein expression"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9873-3285","authenticated-orcid":false,"given":"J\u0119drzej","family":"Borowczak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edyta","family":"Podemska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Drobnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Gawrych","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0141ukasz","family":"Szylberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Bodnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"4181_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"4181_CR2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jama.2011.1142","volume":"306","author":"ND Freedman","year":"2011","unstructured":"Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011;306:737\u201345.","journal-title":"JAMA"},{"key":"4181_CR3","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1007\/s00432-022-04464-6","volume":"149","author":"A \u015alusarczyk","year":"2023","unstructured":"\u015alusarczyk A, Zapa\u0142a P, Zapa\u0142a \u0141, Radziszewski P. The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol. 2023;149:2673\u201391.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4181_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","volume":"15","author":"MA Knowles","year":"2015","unstructured":"Knowles MA, Hurst CD. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer. 2015;15:25\u201341.","journal-title":"Nat Rev Cancer"},{"key":"4181_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, Escrig JLD, et al. European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur Urol. 2022;81:75\u201394.","journal-title":"Eur Urol"},{"key":"4181_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/genes12030333","volume":"12","author":"E De Lorenzis","year":"2021","unstructured":"De Lorenzis E, Albo G, Longo F, Bebi C, Boeri L, Montanari E. Current knowledge on genomic profiling of Upper Tract urothelial carcinoma. Genes. 2021;12:333.","journal-title":"Genes"},{"key":"4181_CR7","volume":"34","author":"A Homami","year":"2020","unstructured":"Homami A, Ataei Kachoei Z, Asgarie M, Ghazi F. Analysis of FGFR3 and HRAS genes in patients with bladder cancer. Med J Islam Repub Iran. 2020;34:108.","journal-title":"Med J Islam Repub Iran"},{"key":"4181_CR8","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/s41467-020-16162-3","volume":"11","author":"JP Sfakianos","year":"2020","unstructured":"Sfakianos JP, Daza J, Hu Y, Anastos H, Bryant G, Bareja R, et al. Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers. Nat Commun. 2020;11:2540.","journal-title":"Nat Commun"},{"key":"4181_CR9","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1038\/s41467-024-46320-w","volume":"15","author":"K Ohara","year":"2024","unstructured":"Ohara K, Rendeiro AF, Bhinder B, Eng KW, Ravichandran H, Nguyen D, et al. The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis. Nat Commun. 2024;15:2009.","journal-title":"Nat Commun"},{"key":"4181_CR10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/mco2.104","volume":"2","author":"T Zhang","year":"2021","unstructured":"Zhang T, Ma C, Zhang Z, Zhang H, Hu H. NF-\u03baB signaling in inflammation and cancer. MedComm. 2021;2:618\u201353.","journal-title":"MedComm"},{"key":"4181_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","volume":"168","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Lenardo MJ, Baltimore D. 30 years of NF-\u03bab: a blossoming of relevance to human pathobiology. Cell. 2017;168:37\u201357.","journal-title":"Cell"},{"key":"4181_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107692","volume":"219","author":"K Fousek","year":"2021","unstructured":"Fousek K, Horn LA, Palena C. Interleukin-8: a chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression. Pharmacol Ther. 2021;219:107692.","journal-title":"Pharmacol Ther"},{"key":"4181_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/cncy.22767","volume":"132","author":"CJ VandenBussche","year":"2024","unstructured":"VandenBussche CJ, Heaney CD, Kates M, Hooks JJ, Baloga K, Sokoll L, et al. Urinary IL-6 and IL-8 as predictive markers in bladder urothelial carcinoma: a pilot study. Cancer Cytopathol. 2024;132:50\u20139.","journal-title":"Cancer Cytopathol"},{"key":"4181_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10735-023-10119-8","volume":"54","author":"CA Basset","year":"2023","unstructured":"Basset CA, Conway de Macario E, Leone LG, Macario AJL, Leone A. The chaperone system in cancer therapies: Hsp90. J Mol Histol. 2023;54:105\u201318.","journal-title":"J Mol Histol"},{"key":"4181_CR15","doi-asserted-by":"publisher","first-page":"8454","DOI":"10.18632\/oncotarget.3502","volume":"6","author":"M Chehab","year":"2015","unstructured":"Chehab M, Caza T, Skotnicki K, Landas S, Bratslavsky G, Mollapour M, et al. Targeting Hsp90 in urothelial carcinoma. Oncotarget. 2015;6:8454\u201373.","journal-title":"Oncotarget"},{"key":"4181_CR16","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3390\/biom12091166","volume":"12","author":"S Maiti","year":"2022","unstructured":"Maiti S, Picard D. Cytosolic Hsp90 isoform-specific functions and clinical significance. Biomolecules. 2022;12:1166.","journal-title":"Biomolecules"},{"key":"4181_CR17","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nrurol.2013.108","volume":"10","author":"J Ischia","year":"2013","unstructured":"Ischia J, So AI. The role of heat shock proteins in bladder cancer. Nat Rev Urol. 2013;10:386\u201395.","journal-title":"Nat Rev Urol"},{"key":"4181_CR18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3349\/ymj.2020.61.7.587","volume":"61","author":"HJ Kim","year":"2020","unstructured":"Kim HJ, Gong MK, Yoon CY, Kang J, Yun M, Cho NH, et al. Synergistic antitumor effects of combined treatment with HSP90 inhibitor and PI3K\/mTOR dual inhibitor in cisplatin-resistant human bladder cancer cells. Yonsei Med J. 2020;61:587\u201396.","journal-title":"Yonsei Med J"},{"key":"4181_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.620907","volume":"11","author":"L Yin","year":"2021","unstructured":"Yin L, Yang Y, Zhu W, Xian Y, Han Z, Huang H, et al. Heat shock protein 90 triggers multi-drug resistance of ovarian cancer via AKT\/GSK3\u03b2\/\u03b2-catenin signaling. Front Oncol. 2021;11:620907.","journal-title":"Front Oncol"},{"key":"4181_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","volume":"22","author":"H Mao","year":"2025","unstructured":"Mao H, Zhao X, Sun S-C. NF-\u03baB in inflammation and cancer. Cell Mol Immunol. 2025;22:811\u201339.","journal-title":"Cell Mol Immunol"},{"key":"4181_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/pros.22761","volume":"74","author":"JE Bohonowych","year":"2014","unstructured":"Bohonowych JE, Hance MW, Nolan KD, Defee M, Parsons CH, Isaacs JS, et al. Extracellular Hsp90 mediates an NF-\u03baB dependent inflammatory stromal program: implications for the prostate tumor microenvironment. Prostate. 2014;74:395\u2013407.","journal-title":"Prostate"},{"key":"4181_CR22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"4181_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repe\u010dka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38:675\u20138.","journal-title":"Nat Biotechnol"},{"key":"4181_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027616","volume":"6","author":"F Koga","year":"2011","unstructured":"Koga F, Yoshida S, Tatokoro M, KawakamiFujii SY, Kumagai J, et al. ErbB2 and NF\u03baB overexpression as predictors of chemoradiation resistance and putative targets to overcome resistance in muscle-invasive bladder cancer. PLoS ONE. 2011;6:e27616.","journal-title":"PLoS ONE"},{"key":"4181_CR25","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1158\/1535-7163.MCT-17-0786","volume":"17","author":"S Inoue","year":"2018","unstructured":"Inoue S, Ide H, Mizushima T, Jiang G, Netto GJ, Gotoh M, et al. Nuclear factor-\u03baB promotes urothelial tumorigenesis and cancer progression via cooperation with androgen receptor signaling. Mol Cancer Ther. 2018;17:1303\u201314.","journal-title":"Mol Cancer Ther"},{"key":"4181_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00428-007-0560-y","volume":"452","author":"G Levidou","year":"2008","unstructured":"Levidou G, Saetta AA, Korkolopoulou P, Papanastasiou P, Gioti K, Pavlopoulos P, et al. Clinical significance of nuclear factor (NF)-kappaB levels in urothelial carcinoma of the urinary bladder. Virchows Arch. 2008;452:295\u2013304.","journal-title":"Virchows Arch"},{"key":"4181_CR27","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s00345-014-1237-1","volume":"32","author":"M Degoricija","year":"2014","unstructured":"Degoricija M, Situm M, Kora\u0107 J, Miljkovi\u0107 A, Mati\u0107 K, Parad\u017eiket M, et al. High NF-\u03baB and STAT3 activity in human urothelial carcinoma: a pilot study. World J Urol. 2014;32:1469\u201375.","journal-title":"World J Urol"},{"key":"4181_CR28","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.5563","volume":"6","author":"S Durairajan","year":"2018","unstructured":"Durairajan S, Jebaraj Walter CE, Samuel MD, Palani D, Davis DJ, Doss GP, et al. Differential expression of NF-\u03baB heterodimer RelA\/p50 in human urothelial carcinoma. PeerJ. 2018;6:e5563.","journal-title":"PeerJ"},{"key":"4181_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/carcin\/bgu321","volume":"36","author":"N Mukherjee","year":"2015","unstructured":"Mukherjee N, Houston TJ, Cardenas E, Ghosh R. To be an ally or an adversary in bladder cancer: the NF-\u03baB story has not unfolded. Carcinogenesis. 2015;36:299\u2013306.","journal-title":"Carcinogenesis"},{"key":"4181_CR30","first-page":"2786","volume":"9","author":"T Karashima","year":"2003","unstructured":"Karashima T, Sweeney P, Kamat A, Huang S, Kim SJ, Bar-Eli M, et al. Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8. Clin Cancer Res. 2003;9:2786\u201397.","journal-title":"Clin Cancer Res"},{"key":"4181_CR31","doi-asserted-by":"publisher","first-page":"9035","DOI":"10.3892\/mmr.2017.7747","volume":"16","author":"Y Guo","year":"2017","unstructured":"Guo Y, Zang Y, Lv L, Cai F, Qian T, Zhang G, et al. IL\u20118 promotes proliferation and inhibition of apoptosis via STAT3\/AKT\/NF\u2011\u03baB pathway in prostate cancer. Mol Med Rep. 2017;16:9035\u201342.","journal-title":"Mol Med Rep"},{"key":"4181_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2490-12-18","volume":"12","author":"ST Reis","year":"2012","unstructured":"Reis ST, Leite KRM, Piovesan LF, Pontes-Junior J, Viana NI, Abe DK, et al. Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of bladder cancer. BMC Urol. 2012;12:18.","journal-title":"BMC Urol"},{"key":"4181_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.bbcan.2019.01.005","volume":"1871","author":"Y Cheng","year":"2019","unstructured":"Cheng Y, Ma X-L, Wei Y-Q, Wei X-W. Potential roles and targeted therapy of the CXCLs\/CXCR2 axis in cancer and inflammatory diseases. Biochim Biophys Acta Rev Cancer. 2019;1871:289\u2013312.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"4181_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.990568","volume":"12","author":"M Rizzo","year":"2022","unstructured":"Rizzo M, Varnier L, PezzicoliPirovanoCosmaiPorta GMLC, et al. IL-8 and its role as a potential biomarker of resistance to anti-angiogenic agents and immune checkpoint inhibitors in metastatic renal cell carcinoma. Front Oncol. 2022;12:990568.","journal-title":"Front Oncol"},{"key":"4181_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canlet.2007.05.013","volume":"256","author":"D Raman","year":"2007","unstructured":"Raman D, Baugher PJ, Thu YM, Richmond A. Role of chemokines in tumor growth. Cancer Lett. 2007;256:137\u201365.","journal-title":"Cancer Lett"},{"key":"4181_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13003","volume":"18","author":"MY He","year":"2019","unstructured":"He MY, Xu SB, Qu ZH, Guo YM, Liu XC, Cong XX, et al. Hsp90\u03b2 interacts with MDM2 to suppress p53-dependent senescence during skeletal muscle regeneration. Aging Cell. 2019;18:e13003.","journal-title":"Aging Cell"},{"key":"4181_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.yexcr.2014.05.018","volume":"326","author":"X Xiong","year":"2014","unstructured":"Xiong X, Wang Y, Liu C, Lu Q, Liu T, Chen G, et al. Heat shock protein 90\u03b2 stabilizes focal adhesion kinase and enhances cell migration and invasion in breast cancer cells. Exp Cell Res. 2014;326:78\u201389.","journal-title":"Exp Cell Res"},{"key":"4181_CR38","doi-asserted-by":"publisher","first-page":"10483","DOI":"10.1074\/jbc.M110.112433","volume":"286","author":"C-H Lin","year":"2011","unstructured":"Lin C-H, Cheng H-W, Ma H-P, Wu C-H, Hong C-Y, Chen B-C, et al. Thrombin induces NF-kappaB activation and IL-8\/CXCL8 expression in lung epithelial cells by a Rac1-dependent PI3K\/Akt pathway. J Biol Chem. 2011;286:10483\u201394.","journal-title":"J Biol Chem"},{"key":"4181_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00418-015-1316-4","volume":"144","author":"F Grillo","year":"2015","unstructured":"Grillo F, Pigozzi S, Ceriolo P, Calamaro P, Fiocca R, Mastracci L, et al. Factors affecting immunoreactivity in long-term storage of formalin-fixed paraffin-embedded tissue sections. Histochem Cell Biol. 2015;144:93\u20139.","journal-title":"Histochem Cell Biol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04181-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-04181-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04181-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:32:22Z","timestamp":1779204742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-04181-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["4181"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-04181-9","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study followed the Declaration of Helsinki, and the protocol was approved by the local Bioethics Committee (KB 470\/2012). As this study involved a retrospective analysis of anonymized data, informed consent from the patients was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The Bioethical Committee waived the requirement for patient consent due to the study\u2019s retrospective nature.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}